Monday, December 23, 2024
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

Covid 19

Havana, Oct 28 (Prensa Latina) Cuban President Miguel Díaz-Canel Bermúdez today highlighted the authorization of emergency use of the anti-Covid-19 Abdala vaccine in children from two to 11 years old approved by the national regulatory entity.
Montevideo, Oct 28 (Prensa Latina) The former coordinator of the Uruguayan Honorary Scientific Advisory Group (GACH), Rafael Radi, warned today that the challenging situation of the Covid-19 pandemic will continue despite greater control at present.
Havana, Oct 28 (Prensa Latina) The Cuban Health Ministry reported today 900 new cases with the SARS-Cov-2 virus, that causes Covid-19, and nine deaths in the last hours.
Havana, Oct 27 (Prensa Latina) Cuba today reported 912 new infections with the SARS-Cov-2 virus that causes Covid-19 and nine deaths in the last 24 hours due to complications from this disease.
Havana, Oct 22 (Prensa Latina) Cuba confirmed today 1,476 positive cases for SARS-CoV-2, the cause of Covid-19, and 20 deaths from complications related to the disease, numbers slightly higher than those from yesterday.
Beijing, Oct 20 (Prensa Latina) China closed all tourist resorts in Gansu province (northwest) on Wednesday, after confirming at least six cases of Covid-19 among tourists who traveled there.
Havana, Oct 18 (Prensa Latina) Cuba today reported 1,768 positive cases of SARS-CoV-2, the cause of Covid-19, (76 less than the previous day) and 22 deaths due to complications associated with the pandemic.
Havana, Oct 15 (Prensa Latina) Cuba confirmed today two thousand 138 positive cases for SARS-CoV-2, that causes Covid-19, and 24 deaths from complications associated with the disease, the latter being the lowest figure in past two months.
Moscow, Oct 13 (Prensa Latina) The Gamaleya Center for Epidemiology and Microbiology reported today that the Sputnik Light vaccine is 70 percent effective during the first three months of immunization against the Delta variant of SARS-CoV-2.